VSIR and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), VISTA is highly expressed on myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) within the tumor microenvironment (TME), contributing to immune suppression and resistance to PD-1 blockade.